Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J C Presti

Showing results (1-10 of 61) with videos related to

Pageof 7
Sort By:
Methods in Molecular Medicine|February 15, 2011
Comparative genomic hybridizationJ C Presti
Radiologic Clinics of North America|February 9, 2000
Prostate cancer: assessment of risk using digital rectal examination, tumor grade, prostate-specific antigen, and systematic biopsyJ C Presti
Urology|December 22, 1999
The role of the urologist in adjuvant chemotherapy trials for prostate cancerJ C Presti
The Journal of Urology|September 1, 1988
Lumbar herniation of the kidneyJ C Presti, P Narayan
Seminars in Oncology|April 18, 2000
Contemporary approach to the classification of renal epithelial tumorsV E Reuter, J C Presti
Seminars in Urologic Oncology|August 1, 1996
Use of prostate-specific antigen (PSA) and PSA density in the detection of stage T1 carcinoma of the prostateJ C Presti, P R Carroll
Urology|August 11, 1992
Comparison of plicated and stapled continent ileocecal stomaP R Carroll, J C Presti
The Urologic Clinics of North America|September 5, 1998
Imaging and management of atypical testicular massesF V Coakley, H Hricak, J C Presti
Urologic Oncology|February 13, 2001
p53 immunoreactivity correlates with Ki-67 and bcl-2 expression in renal cell carcinomaA F. Olumi, N Weidner, J C. Presti
Cancer Genetics and Cytogenetics|May 1, 1996
L-MYC allelotype in renal cell carcinomaJ C Presti, J Hinckley, V E Reuter
Pageof 7

Showing results (1-10 of 61) with videos related to

Sort By:
Pageof 7
Methods in Molecular Medicine|February 15, 2011
Comparative genomic hybridizationJ C Presti
Radiologic Clinics of North America|February 9, 2000
Prostate cancer: assessment of risk using digital rectal examination, tumor grade, prostate-specific antigen, and systematic biopsyJ C Presti
Urology|December 22, 1999
The role of the urologist in adjuvant chemotherapy trials for prostate cancerJ C Presti
The Journal of Urology|September 1, 1988
Lumbar herniation of the kidneyJ C Presti, P Narayan
Seminars in Oncology|April 18, 2000
Contemporary approach to the classification of renal epithelial tumorsV E Reuter, J C Presti
Seminars in Urologic Oncology|August 1, 1996
Use of prostate-specific antigen (PSA) and PSA density in the detection of stage T1 carcinoma of the prostateJ C Presti, P R Carroll
Urology|August 11, 1992
Comparison of plicated and stapled continent ileocecal stomaP R Carroll, J C Presti
The Urologic Clinics of North America|September 5, 1998
Imaging and management of atypical testicular massesF V Coakley, H Hricak, J C Presti
Urologic Oncology|February 13, 2001
p53 immunoreactivity correlates with Ki-67 and bcl-2 expression in renal cell carcinomaA F. Olumi, N Weidner, J C. Presti
Cancer Genetics and Cytogenetics|May 1, 1996
L-MYC allelotype in renal cell carcinomaJ C Presti, J Hinckley, V E Reuter
Pageof 7